Published in Invest Ophthalmol Vis Sci on March 01, 2007
Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet (2009) 2.40
Prevalence of cataract in an older population in India: the India study of age-related eye disease. Ophthalmology (2011) 1.19
Prevalence of early and late age-related macular degeneration in India: the INDEYE study. Invest Ophthalmol Vis Sci (2009) 1.05
Dietary sources of lutein and zeaxanthin carotenoids and their role in eye health. Nutrients (2013) 0.99
Drusen prevalence and pigmentary changes in Caucasians aged 18-54 years. Eye (Lond) (2012) 0.89
Prevalence and pattern of vitreo-retinal diseases in Nepal: the Bhaktapur glaucoma study. BMC Ophthalmol (2013) 0.87
An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism. Invest Ophthalmol Vis Sci (2009) 0.85
Prevalence and determinants of age-related macular degeneration in the 50 years and older population: a hospital based study in Maharashtra, India. Indian J Ophthalmol (2013) 0.80
Prevalence and risk factors of early-stage age-related macular degeneration in patients examined at a health promotion center in Korea. J Korean Med Sci (2012) 0.79
Population awareness of diabetic eye disease and age related macular degeneration in Nepal: the Bhaktapur Retina Study. BMC Ophthalmol (2015) 0.79
Prevalence of age-related macular degeneration in Nakuru, Kenya: a cross-sectional population-based study. PLoS Med (2013) 0.79
The prevalence and risk factors for age-related macular degeneration in rural-urban India, Sankara Nethralaya Rural-Urban Age-related Macular degeneration study, Report No. 1. Eye (Lond) (2016) 0.79
Assessment of Choroidal Microstructure and Subfoveal Thickness Change in Eyes With Different Stages of Age-Related Macular Degeneration. Medicine (Baltimore) (2016) 0.76
Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina Study. Clin Ophthalmol (2017) 0.75
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet (2010) 13.86
UK health performance: findings of the Global Burden of Disease Study 2010. Lancet (2013) 6.11
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial. Ophthalmology (2012) 4.70
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet (2006) 3.96
Status of speciality training in ophthalmology in India. Indian J Ophthalmol (2005) 3.70
Millions dead: how do we know and what does it mean? Methods used in the comparative risk assessment of household air pollution. Annu Rev Public Health (2014) 3.65
Population-based multidimensional assessment of older people in UK general practice: a cluster-randomised factorial trial. Lancet (2004) 2.96
Clinical classification of age-related macular degeneration. Ophthalmology (2013) 2.92
The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2012) 2.87
Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol (2006) 2.82
The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis. Ophthalmology (2007) 2.46
Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. Am J Clin Nutr (2010) 2.20
Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr (2006) 2.19
The estimated prevalence and incidence of late stage age related macular degeneration in the UK. Br J Ophthalmol (2012) 2.02
Cause-specific mortality in old age in relation to body mass index in middle age and in old age: follow-up of the Whitehall cohort of male civil servants. Int J Epidemiol (2005) 1.98
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98
Rapid Assessment of Avoidable Blindness in India. PLoS One (2008) 1.95
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2014) 1.95
Depression and anxiety in visually impaired older people. Ophthalmology (2007) 1.94
Pneumonia case-finding in the RESPIRE Guatemala indoor air pollution trial: standardizing methods for resource-poor settings. Bull World Health Organ (2007) 1.90
Effects of immediate versus delayed antihypertensive therapy on outcome in the Systolic Hypertension in Europe Trial. J Hypertens (2004) 1.87
Causes of blindness and visual impairment in Nigeria: the Nigeria national blindness and visual impairment survey. Invest Ophthalmol Vis Sci (2009) 1.80
CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis (2009) 1.74
Age related macular degeneration. BMJ (2003) 1.72
New treatments for neovascular acute macular degeneration. BMJ (2007) 1.69
Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol (2002) 1.67
Prevalence, causes, and risk factors for functional low vision in Nigeria: results from the national survey of blindness and visual impairment. Invest Ophthalmol Vis Sci (2011) 1.55
Current status of cataract blindness and Vision 2020: the right to sight initiative in India. Indian J Ophthalmol (2008) 1.52
Systematic review and meta-analysis of the association between complement component 3 and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2011) 1.42
Prevelence and causes of visual impairment and blindness in older adults in an area of India with a high cataract surgical rate. Ophthalmic Epidemiol (2010) 1.40
Bevacizumab for the treatment of neovascular age related macular degeneration. BMJ (2010) 1.40
Review of the publications of the Nigeria national blindness survey: methodology, prevalence, causes of blindness and visual impairment and outcome of cataract surgery. Ann Afr Med (2012) 1.34
Local area deprivation and urban-rural differences in anxiety and depression among people older than 75 years in Britain. Am J Public Health (2004) 1.31
Detecting chronic kidney disease in older people; what are the implications? Age Ageing (2007) 1.30
Validity of the Clock-Drawing Test as a screening tool for cognitive impairment in the elderly. Am J Epidemiol (2004) 1.30
Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration. Am J Clin Nutr (2008) 1.29
Improving the response rates to questionnaires. BMJ (2002) 1.28
Factors associated with depression in a representative sample of 14 217 people aged 75 and over in the United Kingdom: results from the MRC trial of assessment and management of older people in the community. Int J Geriatr Psychiatry (2003) 1.28
Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Med (2007) 1.27
Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology (2007) 1.26
Statistics teaching in medical school: opinions of practising doctors. BMC Med Educ (2010) 1.25
Sunlight exposure, antioxidants, and age-related macular degeneration. Arch Ophthalmol (2008) 1.21
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19
Prevalence of cataract in an older population in India: the India study of age-related eye disease. Ophthalmology (2011) 1.19
Do doctors need statistics? Doctors' use of and attitudes to probability and statistics. Stat Med (2009) 1.18
Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17
Age-related macular degeneration causing visual impairment in people 75 years or older in Britain: an add-on study to the Medical Research Council Trial of Assessment and Management of Older People in the Community. Ophthalmology (2004) 1.17
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16
Visual impairment and quality of life in the older European population, the EUREYE study. Acta Ophthalmol (2009) 1.14
Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype. Int J Epidemiol (2012) 1.12
Morphology-dependent zeolite intergrowth structures leading to distinct internal and outer-surface molecular diffusion barriers. Nat Mater (2009) 1.11
Pharmacogenetic associations with vascular endothelial growth factor inhibition in participants with neovascular age-related macular degeneration in the IVAN Study. Ophthalmology (2013) 1.11
Evidence for association of endothelial nitric oxide synthase gene in subjects with glaucoma and a history of migraine. Invest Ophthalmol Vis Sci (2005) 1.10
Psychophysical function in age-related maculopathy. Surv Ophthalmol (2009) 1.09
EPHA2 polymorphisms and age-related cataract in India. PLoS One (2012) 1.06
Human resources and infrastructure for eye care in India: current status. Natl Med J India (2004) 1.06
Prevalence and vision-related outcomes of cataract surgery in Gujarat, India. Ophthalmic Epidemiol (2009) 1.05
Prevalence of early and late age-related macular degeneration in India: the INDEYE study. Invest Ophthalmol Vis Sci (2009) 1.05
Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study. Ophthalmic Epidemiol (2004) 1.05
Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. Invest Ophthalmol Vis Sci (2008) 1.04
Blood levels of vitamin C, carotenoids and retinol are inversely associated with cataract in a North Indian population. Invest Ophthalmol Vis Sci (2008) 1.03
Presbyopia and near-vision impairment in rural northern China. Invest Ophthalmol Vis Sci (2011) 1.02
AMD and micronutrient antioxidants. Curr Eye Res (2004) 1.02
Are older people dying of depression? Findings from the Medical Research Council trial of the assessment and management of older people in the community. J Am Geriatr Soc (2005) 1.01
Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration. Ophthalmology (2012) 1.00
Fundus autofluorescence in age-related macular degeneration: an epiphenomenon? Invest Ophthalmol Vis Sci (2006) 0.97
Is the NEI-VFQ-25 a useful tool in identifying visual impairment in an elderly population? BMC Ophthalmol (2006) 0.95
Cause-specific visual impairment and mortality: results from a population-based study of older people in the United Kingdom. Arch Ophthalmol (2005) 0.94
Associations between chronic kidney disease and age-related macular degeneration. Ophthalmic Epidemiol (2009) 0.94
DNA-based eye colour prediction across Europe with the IrisPlex system. Forensic Sci Int Genet (2011) 0.94
Prevalence and risk factors for diabetes and diabetic retinopathy: results from the Nigeria national blindness and visual impairment survey. BMC Public Health (2014) 0.93
Vitamin C is associated with reduced risk of cataract in a Mediterranean population. J Nutr (2002) 0.93
Trends in influenza vaccination uptake among people aged over 74 years, 1997-2000: survey of 73 general practices in Britain. BMC Fam Pract (2004) 0.93
Association of quality of life in old age in Britain with socioeconomic position: baseline data from a randomised controlled trial. J Epidemiol Community Health (2004) 0.93
The at-risk registers in severe asthma (ARRISA) study: a cluster-randomised controlled trial examining effectiveness and costs in primary care. Thorax (2012) 0.93
Prevalence of lens opacities in North India: the INDEYE feasibility study. Invest Ophthalmol Vis Sci (2007) 0.93